title: Infliximab single administration followed by acute liver injury.
authors.forename: Enzo
authors.initials: E
authors.lastname: Ierardi
authors.forename: Nicola
authors.initials: N
authors.lastname: Della Valle
authors.forename: Maurizio Cosimo
authors.initials: MC
authors.lastname: Nacchiero
authors.forename: Vincenzo
authors.initials: V
authors.lastname: De Francesco
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Stoppino
authors.forename: Carmine
authors.initials: C
authors.lastname: Panella
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D008099:Liver / Q000187:drug effects* / Q000201:enzymology* / Q000473:pathology; D008297:Male
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab